Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 01 Jul 2024 09:15:40 +0200Thu, 04 Jan 2024 10:50:00 +0100Human medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 12/12/2018, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/dengvaxiaHuman medicines European public assessment report (EPAR): Dengvaxia, dengue tetravalent vaccine (live, attenuated), Date of authorisation: 12/12/2018, Revision: 6, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/dengvaxiaThu, 04 Jan 2024 10:50:00 +0100Human medicineDengvaxia : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4171-en.pdfDengvaxia : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4171-en.pdfThu, 04 Jan 2024 02:00:00 +0100Human medicine